首页> 美国卫生研究院文献>BMJ Case Reports >Idiopathic multicentric Castleman disease preceded by cutaneous plasmacytosis successfully treated by tocilizumab
【2h】

Idiopathic multicentric Castleman disease preceded by cutaneous plasmacytosis successfully treated by tocilizumab

机译:特识内的特性多级卡斯克氏症其前一种皮肤纤维化症成功地由康公然植物治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A woman aged 45 years with a 1.5-year history of violaceous plaques on the forehead and chest presented with fever, weight loss and aggravation of the plaques. Inflammatory markers and interleukin-6 level were elevated, and superficial lymphadenopathies and splenomegaly were identified by CT scan. Immunohistochemical findings of the lymph node and the skin showed polyclonal plasmacytosis and follicular hyperplasia, leading to the diagnosis of idiopathic multicentric Castleman disease (iMCD) after human herpesvirus-8 infection was excluded. The patient was successfully treated with anti-interleukin-6 receptor antibody, tocilizumab, following relapse after prednisolone therapy.
机译:一个45岁的妇女,在额头和胸部的迫害斑块的1.5年历史上呈现出发烧,减肥和斑块加重。炎症标志物和白细胞介素-6水平升高,CT扫描鉴定出浅表淋巴结病和脾肿大。淋巴结和皮肤的免疫组织化学发现显示多克隆血浆和滤泡性增生,导致人类疱疹病毒-8感染后特发性多中心卡斯曼病(IMCD)的诊断。通过抗白细胞介素-6受体抗体,对泼尼松酮疗法复发后,用抗白细胞介素-6受体抗体进行成功处理。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号